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1. Introduction
  Staphylococcus aureus (S. aureus) is one of the most 
frequently isolated bacterial pathogens in hospital-
acquired infections[1] as well as a common cause of 
community-acquired infections including endocarditis, 
osteomyelitis, septic arthritis, pneumonia and abscesses[2]. 
It is also a significant pathogen in economically important 
animals[3]. Staphylococcal resistance to first line drugs like 
synthetic penicillins has resulted in major problems to treat 
methicillin resistant S. aureus (MRSA) variants, which are 
increasingly common[4]. Of greater concern is the recent 
emergence of MRSA variants with reduced susceptibility to 
vancomycin, the antibiotic of last resort[5]. The emergence 
of vancomycin-intermediate S. aureus (VISA) variants 
raises specter of -untreatable staphylococcal infections, 
suggesting a search for alternative therapies[6]. Evidences 
also support the contribution of plant antimicrobials to treat 
the microbial infections[7].
  Withania somnifera (W. somnifera) (L) Dunal, family 
solanaceae, commonly known in Bengali as Ashwagandha[8] 
is found throughout the drier region of India. It is a small 
perennial shrub of about 30 cm to 1.5 m in height. Dried 
roots and leaves are used as crude drug. Traditionally 
it is used internally to tone the uterus after miscarriage 
and for treatment of post partum difficulties. It is applied 
externally as a poultice to boils, swellings and other painful 
body parts. Immunomodulatory activity of Ashwagandha 
has been shown by some workers[9]. It is known for its 
cardioprotective property and also has hypoglycemic, 
diuretic and hypocholesterolemic effect[9]. Research 
suggests both roots and leaves of Ashwagandha possess 
antibacterial property[10]. The present communication 
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reports the antibacterial property of W. somnifera root 
extracts against MDR S. aureus variants including VISA 
isolates in and around Kolkata, India during 2008-2009.
2. Materials and methods
2.1. Plant Materials
  Whole roots of the plant, W. somnifera were collected 
from Purulia district of West Bengal in the middle of 
November 2009 and authenticated by the department of 
taxonomy, Shyamadas Baidya Shastrapith, Kolkata, West 
Bengal, India[11]. A voucher specimen was deposited in the 
department of Clinical and Experimental Pharmacology, 
School of Tropical Medicine, Kolkata. The freshly collected 
plant materials (root samples) were washed with tap water 
and finally with distilled water. Then the washed root 
samples were shade dried, pulverized mechanically to fine 
powder and stored in an airtight sterile glass container at 
4 ℃ for future use. All experiments were performed with 
the same plant material within ten months from the date of 
collection.
2.2. Preparation of extracts
2.2.1. Aqueous extract
  For aqueous extraction, 20 g of air-dried, powdered plant 
material was added to 200 mL double distilled water (DDH2O) 
taken in a 500 mL conical flask (graduated) and boiled for 
2 h. The volume of the extract was maintained to 200 mL 
by adding DDH2O time to time. It was then filtered through 
cotton wool and centrifuged at 10 000 g for 15 min. The 
volume of the collected supernatant was 178 mL (approx). 
The solution thus obtained was evaporated to about 40 mL. 
This concentrated solution was quantitatively transferred to 
a 50 mL volumetric sterile flask and volume was made up 
with sterile DDH2O. This solution was stored at 4 ℃ to use as 
water extract W. somnifera.
2.2.2. Preparation of methanol (MeOH) extract
  20 g of air-dried, powdered plant material was added to 
200 mL of methanol (A.R) taken in a 500 mL conical flask. 
The flask was plugged with cotton plug and kept on a rotary 
shaker at 200-220 rpm for 24 h. It was then filtered through 
cotton wool and centrifuged at 10 000 g for 20 min. The 
supernatant was then collected and evaporated on a rotary 
evaporator under reduced pressure to yield a brownish 
mass. 300 mg of this brownish mass (methanol extract) was 
dissolved in 3 mL of pure DMSO (dimethyl sulphoxide). This 
solution (100 mg/mL) was labelled as W. somnifera(m).
2.2.3. Preparation of ethanol (EtOH) extract
  To prepare ethanol extract, 96% ethanol was used and rest 
of the procedure was as described as for the MeOH extract. 
DMSO solution of the EtOH extract (100 mg/mL) was labelled 
as W. somnifera(e).
2.2.4. Preparation of normal butanol (n-BuOH) fraction
  A part of methanol extract (1.5 g) was partitioned between 
normal butanol and DDH2O. The normal butanol soluble 
fraction was separated and evaporated under reduced 
pressure. On complete removal of the solvent, the organic 
fraction (n-BuOH part) yielded a dark brown mass. 300 mg 
of this mass was dissolved in 3 mL of pure DMSO and the 
solution (100 mg/mL) was labelled as W. somnifera(b).
2.3. Microorganisms
  A total of 100 local isolates (hospital environments and 
fingers of health care providers) and 50 clinical samples 
(pus/blood/urine) were placed under the study. Amongst 
the 100 local isolates and 50 patient isolates, multi drug 
resistance was observed in 15 and 5 S. aureus variants 
respectively. One vancomycin intermediate S. aureus (VISA) 
(MIC = 6 毺g/mL) [12,13] was also found amongst the 15 locally 
isolated MDR variants.
2.4. Selection of MDR S. aureus variants
  For selection of MDR varieties of S. aureus amongst 150 
isolates, agar disc diffusion method (NCCLS; 2003, Approved 
standard M2-A8)[14] was employed. Standard antibiotic 
discs were used to evaluate the susceptibility pattern of 
the isolates. VISA confirmation was done following the agar 
dilution method (NCCLS; 2000, Approved standard M7-A5)[15].
2.5. Antibacterial assay
2.5.1. Agar well diffusion assay
  For determination of antibacterial efficacy, different 
root extracts of W. somnifera were subjected to agar well 
diffusion following the method of Karou et al[16], 2006 with 
slight modifications. Selected S. aureus variants were first 
incubated at 35 ℃ on Mueller-Hinton agar (MHA) plates 
for 18 h. After incubation, microorganisms were suspended 
in sterile 0.85% saline (NaCl) water and the turbidity of 
the constituted organisms was adjusted to a turbidity of 0.5 
McFarland standard (108 CFU/mL)[16]. Previously prepared 
MHA plates were then uniformly inoculated with the 
prepared bacterial suspensions. For the agar well diffusion, 
wells of 6 mm diameter were cut with the help of a cork-
borer in the surface of the MHA plate(s) and 50 毺L of the 
prepared aqueous solution as well as the prepared organic 
solutions (100 mg/mL) of the plant material [W. somnifera(m), 
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W. somnifera(e), W. somnifera(b)] were introduced into the 
individual wells separately[16]. The test compounds were 
then allowed to diffuse into the MHA at room temperature for 
half an hour before incubation. After overnight incubation of 
the plates at 35 ℃, the inhibition zone diameter (IZD) around 
the test wells were measured. Total zone diameter greater 
than 10 mm including the well was considered to indicate 
susceptibility of the microorganism to the test compounds. 
For all the bacterial strains pure solvents were used as 
controls. The experiments were done thrice and the mean 
values are presented.
3. Results
  Agar well diffusion assay was performed with fifteen 
locally isolated varieties of MDR S. aureus (L1-L15) as well 
as with five patient isolates (P1-P5). Amongst the selected 
20 MDR isolates (L1-L15 & P1-P5), all strains except L14 
were found to be sensitive to vancomycin but all were 
resistant to methicillin. L14 was detected as VISA. L1-L7 was 
also resistant to amoxycillin (10 毺g/disc), amoxy-clav 
(20-10 毺g/disc), cephazolin (30 毺g/disc), cephalexin
(30 毺g/disc). Different degrees of sensitivity against 
gentamycin (30 毺g/disc), ceftriaxone (30 毺g/disc), 
cephoxitin (30 毺g/disc), ciprofloxacin (5 毺g/disc) and 
trmethoprim (10 毺g/disc) were observed in L1-L7.
  In L8-L15 resistance were observed against amoxycillin
(10 毺g/disc), amoxy-clav (20-10 毺g/disc), cephazolin
(30 毺g/disc), cephalexin (30 毺g/disc), ceftriaxone
(30 毺g/disc), cephoxitin (30 毺g/disc) and ciprofloxacin 
(5 毺g/disc). L8-L15 showed different degrees of sensitivity 
pattern against gentamycin (30 毺g/disc). L9-L15 was 
found to be resistant to trimethoprim (10 毺g/disc) but L8 
was identified as sensitive to trimethoprim. P1-P5 showed 
resistance against amoxycillin (10 毺g/disc), amoxy-clav 
(20-10 毺g/disc), cephazolin (30 毺g/disc), cephalexin
(30 毺g/disc), ceftriaxone (30 毺g/disc), cephoxitin
(30 毺g/disc) except P2. Only P2 was sensitive to ceftriaxone 
and cephoxitin. All patient isolates were resistant to 
ciprofloxacin (5 毺g/disc) except P1 and except P5 all were 
resistant to trimethoprim (10 毺g/disc). P3 and P5 were 
found to be resistant against gentamycin (30 毺g/disc) but 
P1, P2 and P4 were detected as sensitive. However the data 
reported in Table 1, shows antibacterial efficacy of aqueous 
solution [W. somnifera(a)] as well as the prepared solution 
of methanol extract [W. somnifera(m)] , ethanol extract [W. 
somnifera(e)]  and the n-butanol fraction [W. somnifera(b)] 
of methanol extract of W. somnifera roots in terms of average 
IZD in mm. The aqueous extract showed least activity where 
as the n-BuOH fraction was found to be most effective. The 
MeOH and EtOH extracts showed moderate efficacy. Solvent 
controls did not show any significant zone to interpret.
4. Discussion
  Since plants have co-evolved with pathogens, they 
justifiably have developed the chemical defense mechanisms 
against the parasitic microbes. Therefore, it is logical to 
anticipate the presence of a variety of compounds in plants 
with specific as well as general antimicrobial activity[19]. 
So far literature is concerned[18], we have several groups of 
phytochemicals like steroidal lactones, alkaloids, flavonoids, 
tannins etc that can be isolated from the plant, W. somnifera. 
The diversified bioactivity of the plant was attributed[21] due 
to the presence of these chemical constituents. The activity 
of the extracts from the plant material is largely dependent 
on the type of solvent used in the extraction procedure[22]. 
The traditional practitioners primarily make use of water as 
a solvent but in our study it was unequivocally established 
that the extracts with organic solvents were much more 
effective in comparison to aqueous and so it can be opined 
that the better solubility of the active components in organic 
solvents was the reason behind this[18]. These findings 
strongly suggest that the organic compounds present in 
MeOH and EtOH extracts as well as in BuOH fraction are 
the active principles[22]. The fact is that, the n-butanolic 
fraction of methanol extract, devoid of inorganic compounds 
(different salts) showed enhanced activity in comparison to 
the methanol extract. The major chemical constituents of 
the Withania sp, the withanolides, are a group of naturally 
Table 1
In vitro antibacterial activity of W. somnifera root extracts against MDR 
S. aureus variants expressed by IZD (mm).
Strains W. sormnifera(a) W. sormnifera(m) W. sormnifera(e) W. sormnifera(b)
L1 12 16 15 21
L2 11 15 14 20
L3 12 16 15 20
L4 11 15 14 19
L5 11 15 14 19
L6 12 16 15 20
L7 12 16 15 20
L8 11 15 14 19
L9 10 15 14 19
 L10 10 15 14 19
 L11 11 16 15 20
 L12 11 15 14 19
 L13 10 15 14 19
 L14 10 15 14 19
 L15 11 15 14 19
P1 11 16 15 20
P2 12 16 15 21
P3 10 14 13 19
P4 11 15 14 19
P5 11 15 14 19
L1-L15: Local isolates; P1-P5: Patient isolates; W. sormnifera(a): 
aqueous extract; W. sormnifera(m): DMSO solution of MeOH extract; 
W. sormnifera(e): DMSO solution of EtOH extract; W. sormnifera(b): 
DMSO solution of n-BuOH fraction of MeOH extract; IZD: Inhibition 
zone diameter.
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occurring C28-steroidal lactone triterpenoids built on an 
intact or rearranged ergostane framework[22], in which C-22 
and C-26 are appropriately oxidized to form a six-membered 
lactone ring[23]. Presence of alkaloids and steroidal lactones 
(Withanolides) in the root extracts of W. somnifera might 
have played the key role to prove efficacy against MDR S. 
aureus variants. However further investigations are very 
much required to isolate the active principles in pure form 
and in our opinion, these bioactive principles may be the 
alternative therapeutic agents for MDR staphylococcal 
infections and thus may help preserve the efficacy of 
antibiotics.
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